磁共振引导下热消融治疗肝肿瘤中国专家共识(2025版)
该共识由中国抗癌协会肿瘤消融治疗专业委员会等多个学会组织国内专家多学科讨论制定,旨在规范并推广MRI引导下肝肿瘤热消融治疗。主要内容涵盖适应证与禁忌证及特点、MRI磁体与引导序列及兼容性热消融设备器械、操作规程与疗效评价及并发症防治。
要点
- MRI引导下肝肿瘤热消融具有无电离辐射、软组织对比度好、多参数任意平面成像等优点。
- 术中可无创实时测温监控热场,术后可精准评价疗效。
- 共识涵盖适应证、禁忌证、设备器械、操作规程、疗效评价与并发症防治。
核心结论
- 共识旨在规范及推广我国MRI引导下肝肿瘤热消融治疗技术,推动影像引导下热消融治疗肿瘤技术的发展,提高肝肿瘤「精准消融」治疗水平。
研究设计与样本
- 由中国抗癌协会肿瘤消融治疗专业委员会、中国临床肿瘤学会肿瘤消融治疗专家委员会、国家卫生健康委员会综合介入质控中心肿瘤消融亚专业组、中国医师协会肿瘤消融治疗技术专家组及中国医师协会介入医师分会肿瘤消融专家工作组组织国内相关专家讨论制定。
诊断标准与关键数值
- 共识内容包括MRI引导下热消融治疗肝肿瘤的适应证、禁忌证及特点。
- 共识内容包括MRI磁体、引导序列、MRI兼容性热消融设备及器械。
- 共识内容包括MRI引导下热消融治疗肝肿瘤操作规程、疗效评价和并发症防治。
临床应用与阅片要点
- 共识围绕MRI引导下肝肿瘤热消融的适应证与禁忌证、设备器械选择、操作规程、疗效评价及并发症防治给出规范。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Image-guided thermal ablation (IGTA) has been widely used in the treatment of liver tumors. MRI-guided thermal ablation of liver tumors offers several advantages, including the absence of ionizing radiation; excellent soft-tissue contrast; multi-parametric and multiplanar imaging; non-invasive, real-time temperature monitoring of the thermal field during the procedure; and accurate post-procedural assessment of therapeutic efficacy. To standardize and promote MRI-guided thermal ablation for liver tumors in China, advance the technological development of IGTA for tumor treatment, and enhance the efficacy of "precision ablation" for hepatic tumors, this expert consensus (2025 edition) was collaboratively developed by national experts from multiple societies and committees through multidisciplinary discussions. The contributing groups included the Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association, the Ablation Expert Committee of the Chinese Society of Clinical Oncology (CSCO), the Tumor Ablation Subgroup of the National Health Commission Comprehensive Interventional Therapy Quality Control Center, the Expert Group on Tumor Ablation Therapy of the Chinese Medical Doctors Association, and the Tumor Ablation Committee of the Chinese College of Interventionalists. The main contents of the consensus include: (1) indications, contraindications, and characteristics of MRI-guided thermal ablation for liver tumors; (2) MRI magnets, guidance sequences, and MRI-compatible thermal ablation equipment and instruments; and (3) protocols for MRI-guided thermal ablation of liver tumors, efficacy assessment, and the prevention and management of complications.
影像引导下热消融(IGTA)技术已经广泛应用于肝肿瘤的治疗。磁共振(MRI)引导下肝肿瘤热消融治疗具有无电离辐射、良好的软组织对比度、多参数及任意平面成像、术中无创测温监控热场、术后疗效评价精准等优点。为了规范及推广我国MRI引导下肝肿瘤热消融治疗技术,推动IGTA治疗肿瘤技术的发展,提高肝肿瘤“精准消融”治疗水平,由中国抗癌协会肿瘤消融治疗专业委员会、中国临床肿瘤学会(CSCO)肿瘤消融治疗专家委员会、国家卫生健康委员会综合介入质控中心肿瘤消融亚专业组、中国医师协会肿瘤消融治疗技术专家组及中国医师协会介入医师分会肿瘤消融专家工作组组织国内相关专家,讨论制定了《磁共振引导下热消融治疗肝肿瘤中国专家共识(2025版)》。主要内容包括:(1)MRI引导下热消融治疗肝肿瘤的适应证、禁忌证及特点;(2)MRI磁体、引导序列、MRI兼容性热消融设备及器械;(3)MRI引导下热消融治疗肝肿瘤操作规程、疗效评价和并发症防治。.
引用
- [Chinese expert consensus on MRI-guided thermal ablation for liver tumors (2025 edition)]. Zhonghua Nei Ke Za Zhi. 2025. PMID: 41218875. doi:10.3760/cma.j.cn112138-20250627-00369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。